                                                                                                                                                                                      Enzi says biodefense bill must promote development of new drugs to combat infectious diseases  July 15  2005  Washington  D C   Senator Mike Enzi  R Wyo   Chairman of the Senate Health  Education  Labor and Pensions  HELP  Committee  today said Congress must encourage pharmaceutical manufacturers to step up development of new drugs to combat infectious diseases as part of legislation being developed to enhance the nations bioterrorism defense     At present  our pharmaceutical industry is not commercializing enough drugs to fight infectious diseaseswhether they are spread naturally or the result of intentional or accidental man made acts  Enzi said Thursday  during a HELP Subcommittee on Bioterrorism and Public Health Preparedness Round Table     The lack of productivity in this area is not a market failure  but a reaction to the incentives that encourage companies to allocate resources to tackle chronic diseases instead of infectious diseases  Enzi added  We must enact legislation that encourages new resources to be allocated to address the threat posed by infectious diseases    Enzi said a comprehensive bioterrorism bill  which Subcommittee Chairman Richard Burr  R N C   is now leading the Committee in developing  will include provisions to encourage product development  strengthen the public health care system  and protect the nations food supply     Our bill must address all of these challenges while also helping enable us to respond effectively and immediately to a biological outbreak or a bioterror attack  he said  The attacks last week in London served as a harsh reminder of the importance of the job that is before us     Enzi added that he hopes the forthcoming biodefense bill will spur the development of new drugs to fight infectious disease  much like the orphan drug legislation championed by the HELP Committees Ranking Member  Senator Edward M  Kennedy  D Mass   and Senator Orrin Hatch  R Utah  led to new treatments to orphan diseases like multiple sclerosis    Although in the past couple years we have made remarkable strides in the effort to identify and address our nations weaknesses with regard to biological threats  the fact remains that more must be done  Enzi said       end                                                        July 2005 News Releases           Browse by                                                                                                                                                                                             Current record                                                                                                                                                                                                                                                                                                                                                                                       